Fig. 7From: The cannabinoid receptor I (CB1) enhanced the osteogenic differentiation of BMSCs by rescue impaired mitochondrial metabolism function under inflammatory conditionThe effect of CB1 on MAPK signal pathways in hBMSCs. A–C 10 μM AM251 was used to treat the CB1 over-expressed BMSCs for 4 h, 20 μM SB203580 or 20 μM SP600125 was used to treat the CB1 over-expressed BMSCs for 2 h, Western blot results showed the expression of phosphorylated p38 MAPK, JNK and Erk1/2, and p38 MAPK, JNK, and Erk1/2 in BMSCs. Histone H3 was used as an internal control. B, C The Real-time RT-PCR results of Nrf1 (B) and Nrf2 (C) expressions in BMSCs. GAPDH was used as an internal control. One-way ANOVA was performed to determine statistical significance. Error bars represent the SD (n = 3). *P ≤ 0.05; **P ≤ 0.01Back to article page